Liminatus Pharma (LIMN) Selling, General & Administrative (2024 - 2026)
Liminatus Pharma's Selling, General & Administrative came in at $778,908 for Q2 2026, down 30.3% from $1.12 million a year earlier but up 11.1% from the prior quarter.
Powered by 
Analysis
Liminatus Pharma (LIMN) Selling, General & Administrative (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Liminatus Pharma reported Selling, General & Administrative of $3.07 million, up 76.6% year-over-year; for FY2025, it was $2.97 million, up 360.4% from FY2024.
- Going back by year, Selling, General & Administrative was $644,619 in FY2024.
- The five-year range for quarterly Selling, General & Administrative is $167,077 (Q4 2024) to $1.12 million (Q2 2025).
- Year-over-year, Selling, General & Administrative increased in four of the last five quarters, with growth averaging 262.8%.
- Business Quant data shows LIMN's Selling, General & Administrative at $700,898 (Q1 2026), $884,211 (Q4 2025) and $701,170 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Liminatus Pharma | 4.24 Mn | 4.24 Mn | - | 778,908.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 778,908.00 |
| Mar 31, 2026 | 700,898.00 |
| Dec 31, 2025 | 884,211.00 |
| Sep 30, 2025 | 701,170.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 264,220.00 |
| Dec 31, 2024 | 167,077.00 |
| Sep 30, 2024 | 186,081.00 |
| Jun 30, 2024 | 195,084.00 |
API Access
Liminatus Pharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LIMN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "LIMN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LIMN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();